New EU Limits On Pyrrolizidine Alkaloids In Dietary Supplements Take Effect
Executive Summary
Following a transitional period of 18 months, maximum levels for pyrrolizidine alkaloids in dietary supplements come into force in the EU from 1 July 2022 for new products placed on the market. Pyrrolizidine alkaloids have been under scrutiny in the EU for over a decade as their consumption has been linked to a number of health issues, including liver damage.
You may also be interested in...
EU CBD Novel Food Applications On Hold As EFSA Considers Health Risks
All European Union CBD novel food applications have been paused by EFSA after its Panel on Nutrition, Novel Foods and Food Allergens raised concerns about the ingredient's safety, pointing in a wide-ranging scientific literature review to a number of data gaps related to bioavailability, liver damage, gastrointestinal issues and possible negative impacts on pregnancy and reproductive health.
EFSA Considers Vitamin D Max Levels As Part Of VMS Evidence Review
Vitamin D is one of eight micronutrients being reviewed by the European Food Safety Authority in terms of tolerable upper intake levels (ULs).
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.